Tata Memorial Centre Evidence Based Management of Colorectal cancer

Indian J Cancer. 2024 Jan 1;61(Suppl 1):S29-S51. doi: 10.4103/ijc.ijc_66_24. Epub 2024 Mar 1.


This review article examines the evidence-based management of colorectal cancers, focusing on topics characterized by ongoing debates and evolving evidence. To contribute to the scientific discourse, we intentionally exclude subjects with established guidelines, concentrating instead on areas where the current understanding is dynamic. Our analysis encompasses a thorough exploration of critical themes, including the evidence surrounding complete mesocolic excision and D3 lymphadenectomy in colon cancers. Additionally, we delve into the evolving landscape of perioperative chemotherapy in both colon and rectal cancers, considering its nuanced role in the context of contemporary treatment strategies. Advancements in surgical techniques are a pivotal aspect of our discussion, with an emphasis on the utilization of minimally invasive approaches such as laparoscopy and robotic surgery in both colon and rectal cancers, including advanced rectal cases. Moving beyond conventional radical procedures, we scrutinize the feasibility and implications of endoscopic resections for small tumors, explore the paradigm of organ preservation in locally advanced rectal cancers, and assess the utility of total neoadjuvant therapy in the current treatment landscape. Our final segment reviews pivotal trials that have significantly influenced the management of colorectal liver and peritoneal metastasis.

Publication types

  • Review

MeSH terms

  • Humans
  • Laparoscopy* / methods
  • Neoadjuvant Therapy
  • Neoplasms, Second Primary* / surgery
  • Rectal Neoplasms* / pathology
  • Rectum / pathology